Bühring KU - Search Results

1

Studies comparing in vivo:in vitro metabolism of three pharmaceutical compounds in rat, dog, monkey, and human using cryopreserved hepatocytes, microsomes, and collagen gel immobilized hepatocyte cultures.

Hewitt NJ, Bühring KU, Dasenbrock J, Haunschild J, Ladstetter B, Utesch D. Hewitt NJ, et al. Among authors: buhring ku. Drug Metab Dispos. 2001 Jul;29(7):1042-50. Drug Metab Dispos. 2001. PMID: 11408372

2

Chlorothiophenecarboxamides as P1 surrogates of inhibitors of blood coagulation factor Xa.

Mederski WW, Cezanne B, van Amsterdam C, Bühring KU, Dorsch D, Gleitz J, März J, Tsaklakidis C. Mederski WW, et al. Among authors: buhring ku. Bioorg Med Chem Lett. 2004 Dec 6;14(23):5817-22. doi: 10.1016/j.bmcl.2004.09.043. Bioorg Med Chem Lett. 2004. PMID: 15501047

3

Glutaminyl Cyclase Inhibitor PQ912 Improves Cognition in Mouse Models of Alzheimer's Disease-Studies on Relation to Effective Target Occupancy.

Hoffmann T, Meyer A, Heiser U, Kurat S, Böhme L, Kleinschmidt M, Bühring KU, Hutter-Paier B, Farcher M, Demuth HU, Lues I, Schilling S. Hoffmann T, et al. Among authors: buhring ku. J Pharmacol Exp Ther. 2017 Jul;362(1):119-130. doi: 10.1124/jpet.117.240614. Epub 2017 Apr 26. J Pharmacol Exp Ther. 2017. PMID: 28446518

4

Pharmacokinetics and first clinical experiences with an antihypertensive dopamine (DA2) agonist.

Meyer W, Bühring KU, Steiner K, Ungethüm W, Schnurr E. Meyer W, et al. Among authors: buhring ku. Eur Heart J. 1992 Sep;13 Suppl D:121-8. doi: 10.1093/eurheartj/13.suppl_d.121. Eur Heart J. 1992. PMID: 1356782 Clinical Trial.

5

Bisoprolol--comparative toxicokinetic study after oral and conjunctival administration in beagles.

Bühring KU, Metallinos A, Jakobs N, von Landenberg F, Merck E. Bühring KU, et al. Lens Eye Toxic Res. 1990;7(3-4):335-45. Lens Eye Toxic Res. 1990. PMID: 1983105

6

The melanin binding of bisoprolol and its toxicological relevance.

Steiner K, Bühring KU, Merck E. Steiner K, et al. Among authors: buhring ku. Lens Eye Toxic Res. 1990;7(3-4):319-33. Lens Eye Toxic Res. 1990. PMID: 1983104

7

Basic pharmacokinetics of bisoprolol, a new highly beta 1-selective adrenoceptor antagonist.

Leopold G, Pabst J, Ungethüm W, Bühring KU. Leopold G, et al. Among authors: buhring ku. J Clin Pharmacol. 1986 Nov-Dec;26(8):616-21. doi: 10.1002/j.1552-4604.1986.tb02959.x. J Clin Pharmacol. 1986. PMID: 2878941

8

Determination of the new beta-blocker bisoprolol and of metoprolol, atenolol and propranolol in plasma and urine by high-performance liquid chromatography.

Bühring KU, Garbe A. Bühring KU, et al. J Chromatogr. 1986 Oct 31;382:215-24. doi: 10.1016/s0378-4347(00)83519-7. J Chromatogr. 1986. PMID: 2878004

9

Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.

Leopold G, Ungethüm W, Pabst J, Simane Z, Bühring KU, Wiemann H. Leopold G, et al. Among authors: buhring ku. Br J Clin Pharmacol. 1986 Sep;22(3):293-300. doi: 10.1111/j.1365-2125.1986.tb02890.x. Br J Clin Pharmacol. 1986. PMID: 2876722 Free PMC article. Clinical Trial.

10

Concentration kinetics of propranolol, bisoprolol, and atenolol in humans assessed with chemical detection and a subtype-selective beta-adrenoceptor assay.

Wellstein A, Palm D, Belz GG, Leopold G, Bühring KU, Pabst J. Wellstein A, et al. Among authors: buhring ku. J Cardiovasc Pharmacol. 1986;8 Suppl 11:S41-5. doi: 10.1097/00005344-198511001-00007. J Cardiovasc Pharmacol. 1986. PMID: 2439797

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters